Quarterly Results • Search Archive
Windlas Biotech Limited
Results, Financials & Updates
Follow Windlas Biotech Limited results and financial updates in one company page: latest revenue or income, profit, margins, quarter comparisons, what changed and detailed Nivata Results deep dives.
1 published deep dive
1 quarter 1 sector
Company Overview
Windlas Biotech Limited: latest results and financials
About the business in Nivata's latest coverage
Windlas Biotech Limited operates as a leading player in the domestic pharmaceutical formulations contract development and manufacturing organization (CDMO) industry in India. The company provides comprehensive services ranging from product discovery, product development, licensing, and commercial manufacturing of generic products. The business model covers three core verticals: Generic Formulations CDMO, Trade Generics & Institutional, and Exports. The company owns the intellectual property and formulation technology for almost all the products it supplies, serving marquee domestic and multinational pharmaceutical clients.
Quarter history
Windlas Biotech Limited Results & Financials
Latest Nivata coverage: Q1 FY27 · revenue ₹248.10 Cr · PAT ₹17.65 Cr.
Nivata currently has one covered quarter for this company. This page remains the stable company-results hub and expands automatically as additional quarters are published.